Ticlopidine Hydrochloride

This page contains recent news articles, when available, and an overview of Ticlopidine Hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Loislaw Federal District Court Opinions - TEVA PHARMACEUTICALS …  -  Oct 21, 2005
We will make no claim of patent infringement based on the sale of ticlopidine hydrochloride tablets having the formulation that [Teva] disclosed to us. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

TICLOPIDINE (Oral route) - tye-KLOE-pi-deen.(Drug overview)  -  May 1, 2007
Ticlopidine hydrochloride can cause life-threatening hematological adverse reactions, ... If any such evidence is seen, ticlopidine hydrochloride should be ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

First Artist Corp PLC acquires ABG Financial Management Ltd (pending)...  -  Jul 22, 2005
Panaldine (ticlopidine hydrochloride) Stroke M…Baxter International Inc. Cleveland Clinic Artist tablet (carvedilol) Congestive Heart Failure… ... Pay-Per-View - deals - Alacra Store

Company Profile Report  -  Sep 13, 2008
Products:. Ticlid (Ticlopidine Hydrochloride). Hypertension. Loop Diuretic Agents ... Products:. Ticlid (Ticlopidine Hydrochloride). Thrombolytic Agents ... $50.00 - Revere Reports - Revere

SHILPA MEDICARE GETS CERTIFICATE OF SUITABILITY FOR …  -  Jul 22, 2005
Till date the company has applied for Ticlopidine Hydrochloride which is under evaluation by the EDQM. With this success the company is gearing to file ... Pay-Per-View - Hindustan Times - Factiva, from Dow Jones

Shilpa Medicare gets licence to market an API in Europe  -  Mar 27, 2006
The ingredient, Ticlopidine Hydrochloride used for treating cardiac related problems and mostly for people who cannot take aspirin to prevent strokes, ... Free with registration - PTI - The Press Trust of India Ltd - AccessMyLibrary.com

Population-Based Drug-Induced Agranulocytosis  -  Apr 25, 2005
The drug most strongly associated with a risk of agranulocytosis was ticlopidine hydrochloride with an odds ratio (OR) of 103.23 (95% confidence interval ... Archives of Internal Medicine

BRIEFING - ASIA RETAIL - MARCH 28, 2006.  -  Mar 28, 2006
The ingredient, Ticlopidine Hydrochloride, used for treating cardiac related problems and mostly for people who cannot take aspirin to prevent strokes, ... $4.95 - AsiaPulse News - ECNext

Press Release: Heritage Announces $10 Million Financing. - PR …  -  Apr 15, 2008
Toradol(R) (ketorolac tromethamine) oral tablets, Ticlid(R) (ticlopidine hydrochloride ... when Syntex first introduced Toradol oral tablets in the United ... Pay-Per-View - PR Newswire - HighBeam Research

BRIEFING - ASIA HEALTH - MARCH 28, 2006.  -  Mar 28, 2006
The ingredient, Ticlopidine Hydrochloride, used for treating cardiac related problems and mostly for people who cannot take aspirin to prevent strokes, ... $4.95 - AsiaPulse News - ECNext

Bleeding Complications Associated With Combinations of Aspirin, …  -  Apr 11, 2005
Background Combinations of aspirin with thienopyridine derivatives (clopidogrel bisulfate or ticlopidine hydrochloride) and/or warfarin sodium are ... Archives of Internal Medicine

Safe use of Cypher Stent and SJS/TEN featured.  -  Nov 7, 2005
...a drug-eluting coronary stent from Johnson and Johnson which administers ticlopidine hydrochloride. Numbers of serious adverse drug reactions are given ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy